Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial. | BMC Neurol | 2023 | 36959618 | PubTator, text mining | PubMed |
| [Modern principles of therapy for patients with spinal muscular atrophy]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2023 | 36946394 | PubTator, text mining | PubMed |
| Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients. | Eur J Med Res | 2023 | 36941660 | PubTator, text mining | PubMed |
| Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy. | Acta Neuropathol | 2023 | 36930296 | PubTator, text mining | PubMed |
| Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. | Science | 2023 | 36927019 | PubTator, text mining | PubMed |
| Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington's disease. | Neural Regen Res | 2023 | 36926717 | PubTator, text mining | PubMed |
| Research progress on non-protein-targeted drugs for cancer therapy. | J Exp Clin Cancer Res | 2023 | 36918935 | PubTator, text mining | PubMed |
| Upregulation of SYNGAP1 expression in mice and human neurons by redirecting alternative splicing. | Neuron | 2023 | 36917980 | PubTator, text mining | PubMed |
| Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG). | J Neuromuscul Dis | 2023 | 36911944 | PubTator, text mining | PubMed |
| Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C. | Mol Ther Nucleic Acids | 2023 | 36910710 | PubTator, text mining | PubMed |
| Copy Number Variation and Structural Genomic Findings in 116 Cases of Sudden Unexplained Death between 1 and 28 Months of Age. | Adv Genet (Hoboken) | 2023 | 36910592 | PubTator, text mining | PubMed |
| Aberrant splicing in human cancer: An RNA structural code point of view. | Front Pharmacol | 2023 | 36909167 | PubTator, text mining | PubMed |
Disturbances of Ocular Circulation in Color Doppler Imaging, Retinal Changes and Electrophysiological Tests with Neuro-Ophthalmological Clinical Symptoms in the Course of CADASIL Syndrome-A Case Report. | J Clin Med | 2023 | 36902751 | PubTator, text mining | PubMed |
| 2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants. | J Clin Med | 2023 | 36902710 | PubTator, text mining | PubMed |
| Pathophysiology and Management of Fatigue in Neuromuscular Diseases. | Int J Mol Sci | 2023 | 36902435 | PubTator, text mining | PubMed |
| A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry. | PLoS One | 2023 | 36897914 | PubTator, text mining | PubMed |
| Reproductive findings in male animals exposed to selective survival of motor neuron 2 (SMN2) gene splicing-modifying agents. | Reprod Toxicol | 2023 | 36894038 | PubTator, text mining | PubMed |
| The TUDOR domain of SMN is an H3K79me1 histone mark reader. | Life Sci Alliance | 2023 | 36882285 | PubTator, text mining | PubMed |
| Chemistry, structure and function of approved oligonucleotide therapeutics. | Nucleic Acids Res | 2023 | 36881759 | PubTator, text mining | PubMed |
| Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function. | Eur J Neurol | 2023 | 36880698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=32